Patent intelligence · US
US 11528924
Alcoholic beverage substitutes
Alcoholic beverage substitutes
Patent details — US 11528924
- Jurisdiction
- US
- Status
- granted
- Grant date
- Dec 20, 2022
- Expiration
- Dec 15, 2042
- Applicant
- CLEARMIND MEDICINE INC.
- Claims
- 11
- CPC classes
- A61K, A61K31/135, A61P, A61P25/32
Quick answer
US 11528924 (Alcoholic beverage substitutes) is held by CLEARMIND MEDICINE INC.. Status: granted. Granted Dec 20, 2022. Expires Dec 15, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- CLEARMIND MEDICINE INC.
- Grant date
- Expiration
- Claims
- 11
- CPC classes
- A61K, A61K31/135, A61P, A61P25/32
More from CLEARMIND MEDICINE INC.
Related pharmaceutical patents in our USPTO index.
Related coverage
Frequently asked questions
What is US patent 11528924?
US 11528924 (Alcoholic beverage substitutes) is held by CLEARMIND MEDICINE INC.. Status: granted. Granted Dec 20, 2022. Expires Dec 15, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11528924?
CLEARMIND MEDICINE INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 5 pharmaceutical patents for this assignee.
When does US 11528924 expire?
Our index shows an expiration date of Dec 15, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.